Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Integral Diagnostics Ltd. ( (AU:IDX) ) has provided an announcement.
Integral Diagnostics has disclosed a change in the indirect shareholding of director James Tobias Hall, reflecting routine participation in the company’s dividend reinvestment plan. Through his self-managed superannuation fund structure, Hall acquired 2,779 additional fully paid ordinary shares at $2.380491 per share, increasing his total holding to 213,271 shares.
The shares were issued under Integral Diagnostics’ dividend reinvestment plan rather than via on-market trading, and there was no disposal of shares or change in contractual interests. The transaction did not occur during a closed trading period, suggesting it is part of standard capital management and director alignment with shareholders rather than a signal of broader strategic change.
The most recent analyst rating on (AU:IDX) stock is a Hold with a A$2.50 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics Ltd. is an Australian healthcare services provider specialising in diagnostic imaging. The company operates radiology clinics that deliver medical imaging services such as X-rays, CT scans, and MRIs to hospitals, specialists, and community referrers across its regional and metropolitan networks.
Average Trading Volume: 853,862
Technical Sentiment Signal: Sell
Current Market Cap: A$879.6M
See more data about IDX stock on TipRanks’ Stock Analysis page.